This invention discloses the application of a
traditional Chinese medicine composition in the preparation of drugs for the prevention and treatment of
gastritis. The composition comprises the following ingredients:
Astragalus membranaceus,
ginseng,
Atractylodes macrocephala, fermented
Cordyceps militaris
powder,
Lycium barbarum,
Hedyotis diffusa,
Fagopyrum dibotrys, Bistorta
officinalis,
Panax notoginseng, and
Caesalpinia sappan. This invention is the first to discover and confirm that this
traditional Chinese medicine composition can be used to prevent or treat
chronic gastritis, especially chronic
atrophic gastritis. Experiments have verified that it can significantly prevent or improve the
pathological state of the
gastric mucosa in rats with chronic
atrophic gastritis. Specifically, it can significantly increase the serum
pepsinogen I / II ratio, decrease
gastrin-17 levels, reverse gastric gland
atrophy, and repair the morphological structure of the
gastric mucosa, achieving a systematic repair of the function and structure of the CAG
gastric mucosa. Furthermore, the ingredients in this
traditional Chinese medicine composition are rationally combined, and no obvious toxic side effects were observed under experimental conditions, demonstrating good safety and potential for long-term use.